Clinicopathologic and metabolic variables from 18F-FDG PET/CT in the prediction of recurrence pattern in stage I–III non-small cell lung cancer after curative surgery

Related articles

1. A prognostic predicting model integrating preoperative 18F-FDG PET/CT metabolic parameter and clinicopathological biomarkers for patients with ccRCC

   This article has 9 authors:

   1. Yuhui Cao
   2. Caixia Wu
   3. Keting Tong
   4. Yulong Chen
   5. Jinzhi Chen
   6. Yuan Gao
   7. Zijian Fu
   8. Xin Wang
   9. Meng Liu

2. Prognostic Value of Ki-67 and 18F-FDG PET/CT SUVmax in Non–Small Cell Lung Cancer

   This article has 2 authors:

   1. Elçin Ersöz Köse
   2. Serda Kanbur Metin

3. A Nomogram Combining Clinical, Metabolic, and Serum Markers to Predict the Risk of Primary Breast Lymphoma Recurrence

   This article has 3 authors:

   1. Tianyi Zhou
   2. Guobao Chen
   3. Shuo Zhou